Recently, Overbeck et al. have added a top-level category of MET-GCNG/GA in NSCLC, corresponding to an average MET-GCN/cell ≥10, which was observed in a subset of poorly differentiated adenocarcinomas with unfavorable prognosis [25]. The gene discussed is MET; the disease is adenocarcinoma.